Susquehanna International Group, LLP Chemo Centryx, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Shares

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$22.17 - $51.8 $2.02 Million - $4.72 Million	-91,188 Reduced 59.15%	62,963 $3.25 Million
Q2 2022 Aug 15, 2022	SELL	$15.36 - $27.51 $279,521 - $500,626	-18,198 Reduced 10.56%	154,151 $3.82 Million
Q1 2022 May 16, 2022	SELL	$22.22 - $39.12 $2.44 Million - $4.29 Million	-109,697 Reduced 38.89%	172,349 $4.32 Million
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $1.08 Million - $2.39 Million	-59,028 Reduced 17.31%	282,046 $10.3 Million
Q3 2021 Nov 15, 2021	SELL	$13.18 - $19.83 $1.02 Million - $1.53 Million	-77,396 Reduced 18.49%	341,074 $5.83 Million
Q2 2021 Aug 11, 2021	BUY	$9.59 - $50.88 $3.91 Million - $20.8 Million	407,847 Added 3839.28%	418,470 $5.6 Million
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $4,556 - $6,292	-92 Reduced 0.86%	10,623 $544,000
Q4 2020 Feb 16, 2021	SELL	$47.25 - $65.16 $518,427 - $714,935	-10,972 Reduced 50.59%	10,715 $663,000
Q3 2020 Nov 16, 2020	SELL	$46.35 - $61.69 $9.86 Million - $13.1 Million	-212,781 Reduced 90.75%	21,687 $1.19 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $842,934 - $1.42 Million	21,849 Added 10.28%	234,468 $13.5 Million
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $4.07 Million - $6.32 Million	124,446 Added 141.14%	212,619 $8.54 Million
Q4 2019 Feb 14, 2020	SELL	$6.81 - $39.55 $1.22 Million - $7.08 Million	-178,921 Reduced 66.99%	88,173 $3.49 Million
Q3 2019 Nov 14, 2019	BUY	$6.47 - $8.96 $1.42 Million - $1.97 Million	219,729 Added 463.91%	267,094 $1.81 Million
Q2 2019 Aug 16, 2019	BUY	$8.31 - $14.85 $252,540 - $451,291	30,390 Added 179.03%	47,365 $440,000
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $36,796 - $65,755	4,428 Added 35.29%	16,975 $158,000
Q4 2018 Feb 14, 2019	SELL	$9.15 - $12.26 $172,074 - $230,561	-18,806 Reduced 59.98%	12,547 $137,000
Q2 2018 Aug 14, 2018	BUY	$10.62 - $13.98 $332,968 - $438,314	31,353 New	31,353 $413,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.